Merck & Co. Inc. | 2013 | FY | 3


Information on available-for-sale investments at December 31 is as follows:
 
 
2013
 
2012
 
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
  
Gains
 
Losses
 
Gains
 
Losses
Corporate notes and bonds
$
7,054

 
$
7,037

 
$
32

 
$
(15
)
 
$
5,063

 
$
5,013

 
$
52

 
$
(2
)
Asset-backed securities
1,300

 
1,303

 
1

 
(4
)
 
837

 
835

 
3

 
(1
)
U.S. government and agency securities
1,236

 
1,239

 
1

 
(4
)
 
1,206

 
1,204

 
2

 

Commercial paper
1,206

 
1,206

 

 

 
2,150

 
2,150

 

 

Mortgage-backed securities
476

 
479

 
2

 
(5
)
 
435

 
436

 
2

 
(3
)
Foreign government bonds
125

 
126

 

 
(1
)
 
108

 
107

 
1

 

Equity securities
471

 
397

 
74

 

 
403

 
370

 
33

 

 
$
11,868

 
$
11,787

 
$
110

 
$
(29
)
 
$
10,202

 
$
10,115

 
$
93

 
$
(6
)

us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock